CONTINUING EDUCATION (CE) LANGUAGE

Title:                   Emerging Therapeutic Frontiers in Pediatric IBD: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologics

Date:                   February 25, 2026

Location:             Online

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). NASPGHAN is accredited by the ACCME to provide continuing medical education for physicians.

ACCME provider number: 0005000

Credit Designation Statement

NASPGHAN designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABP MOC Part 2 Credits

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn up to 1.5 MOC Part 2 points for the live webinar in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Participant must complete the assessment within 30 days of the activity.

As therapeutic options for pediatric inflammatory bowel disease (IBD) rapidly evolve, clinicians must stay current on the next generation of therapies that have the potential to dramatically enhance patient outcomes and quality of life.

Emerging Therapeutic Frontiers in Pediatric IBD brings you an interactive, case-driven webinar that will delve into three groundbreaking areas transforming pediatric IBD care: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologic Medications. 

Expert faculty will guide attendees through mechanisms of action, clinical trial outcomes, real-world evidence, and safety considerations, offering up-to-date insights that bridge cutting-edge research and everyday practice. By the end of this webinar, participants will be equipped with practical strategies to integrate these novel therapies into comprehensive treatment plans, optimize disease monitoring, and collaborate effectively with multidisciplinary teams, ultimately advancing care for children living with IBD.

In this episode of Bowel Sounds, hosts Dr. Temara Hajjat and Dr. Amber Hildreth and talk to Dr. William Balistreri, Dorothy M. M. Kersten Professor of Pediatrics at the University of Cincinnati, Director Emeritus of the Pediatric Liver Center at Cincinnati Children's Hospital, Medical Director Emeritus of Liver Transplantation, and Program Director Emeritus of Transplant Hepatology Fellowship. We talk about the history of the Hepatitis B virus and vaccine, and the new ACIP vaccination recommendations.

For Canadian listeners:

Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege.ca

In this episode of Bowel Sounds, hosts Dr. Jordan Whatley and Dr. Jenn Lee talk to Dr. Naylor Brownell, Pediatric Gastroenterologist and Co-Director of the Pancreatic Disorders Program at the Children's Hospital of Philadelphia, who provides care in the Jill and Mark Fishman Center for Lymphatic Disorders. We talk about lymphatic conditions and their effect on the GI tract, as well as the diagnosis and management of primary intestinal lymphangiectasia.

For Canadian listeners:

Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege.ca

In this episode of Bowel Sounds, hosts Dr. Amber Hildreth and Dr. Peter Lu talk to Dr. Tom Wallach, Assistant Professor of Pediatrics at SUNY Downstate, Chief of Pediatric Gastroenterology, Pediatric GI Fellowship director, and Research Director of Pediatrics. We talk about experience based research and how to implement these tools into medical education.

For Canadian listeners:

Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege.ca

In this episode, hosts Drs. Temara Hajjat and Jason Silverman talk to Dr. Paul Tran about attracting and educating a new generation of learners.

For Canadian listeners:

Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege.ca

A multicentre assessment of adequacy of bowel preparation for paediatric ileocolonoscopy, December 2025 JPGN

Management of Acute Pancreatitis 

Pancreaticobiliary Stones

Management of Acute Pancreatitis 

Pancreaticobiliary Stones

In this episode of Bowel Sounds, hosts Dr. Temara Hajjat talks to Dr. Katja Karrento an Associate Professor at the University of Wisconsin and pediatric gastroenterologist at Wisconsin Children's and an expert on DGBI. Dr. Karrento talks about the 2025 NASPGHAN guidelines for managing children with cyclic vomiting syndrome (CVS). 

For Canadian listeners:

Please note that all listed Bowel Sounds episodes are peer-reviewed and that listening to episodes is considered a Section Two Scanning Activity by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification program. Each episode is valued at 0.5 Section Two Credits. Content is valid on the date recorded but recommendations may change over time. You can document your listening and obtain your CME credits at https://mainport.royalcollege.ca

Functional abdominal pain disorders (FAPDs) are a group of disorders of the gut-brain interaction (DGBIs) and affect up to 25% of children worldwide. Children with FAPDs have an impaired quality of life along with significant risk of psychiatric comorbidities. The pathophysiology of FAPDs is complex and involves numerous biopsychosocial factors, and with up to 40% of children having persistent symptoms despite therapeutic interventions, it is important for the clinician to understand and be comfortable with using the most effective, up to date and evidence based therapeutic strategies for their patient with FAPD. 

This webinar aims to provide the audience with a detailed overview of the approach to FAPDs including evidence-based treatment approach based on FAPD subtypes as per the Rome IV criteria.  Recently, NASPGHAN and ESPGHAN released updated guidelines for the treatment of irritable bowel syndrome (IBS) and functional abdominal pain-not otherwise specified (FAP) in children aged 4-18 years.

Sponsored by an educational grant from NeurAxis